| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
66,921,000 |
| Market
Cap: |
2.83(B) |
| Last
Volume: |
1,212,774 |
Avg
Vol: |
1,000,279 |
| 52
Week Range: |
$38.26 - $93.23 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile QuidelOrtho is engaged in the development, manufacturing and marketing of diagnostic testing solutions. Co. provides diagnostic testing solutions under various brand names, including, among others, the following: Quidel®, QuickVue®, QuickVue+®, Sofia®, Triage®, Solana®, Virena®, MicroVue™, Lyra®, FreshCells™, D3®, FastPoint®, ReadyCells®, Super E-Mix™, InflammaDry®, AdenoPlus®, ELVIRA®, ELVIS® and Thyretain®. Co.'s diagnostic testing solutions are separated into its four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions and specialized diagnostic solutions.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gibson Karen |
SVP, Digital Health |
• – – |
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,970 |
4,440 |
|
- |
|
| Abney Michael Donald Jr. |
SVP - N.A. Sales & Distrib. |
• – – |
2021-01-29 |
4 |
D |
$250.97 |
$208,807 |
D/D |
(832) |
8,772 |
|
- |
|
| Abney Michael Donald Jr. |
SVP - N.A. Sales & Distrib. |
• – – |
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,970 |
9,604 |
|
- |
|
| Polan Mary Lake Ph D |
Director |
– • – |
2020-12-01 |
4 |
S |
$192.25 |
$2,114,797 |
D/D |
(11,000) |
24,329 |
|
31% |
|
| Steward Randall J |
Chief Financial Officer |
• – – |
2020-11-18 |
4 |
D |
$187.28 |
$96,075 |
D/D |
(513) |
3,369 |
|
- |
|
| Steward Randall J |
Chief Financial Officer |
• – – |
2020-11-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,034 |
3,882 |
|
- |
|
| Bujarski Robert Joseph |
Chief Operating Officer |
• – – |
2020-11-18 |
4 |
D |
$187.28 |
$67,046 |
D/D |
(358) |
14,059 |
|
- |
|
| Bujarski Robert Joseph |
Chief Operating Officer |
• – – |
2020-11-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,034 |
14,417 |
|
- |
|
| Borkar Ratan S |
SVP, Intl Comm Operations |
• – – |
2020-11-18 |
4 |
D |
$187.28 |
$193,648 |
D/D |
(1,034) |
524 |
|
- |
|
| Borkar Ratan S |
SVP, Intl Comm Operations |
• – – |
2020-11-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,034 |
1,558 |
|
- |
|
| Polan Mary Lake Ph D |
Director |
– • – |
2020-11-06 |
4 |
S |
$284.17 |
$852,505 |
D/D |
(3,000) |
35,329 |
|
52% |
|
| Slacik Charles P |
Director |
– • – |
2020-11-05 |
4 |
S |
$282.46 |
$1,132,388 |
D/D |
(4,009) |
11,215 |
|
52% |
|
| Slacik Charles P |
Director |
– • – |
2020-11-05 |
4 |
OE |
$20.82 |
$83,467 |
D/D |
4,009 |
15,224 |
|
- |
|
| Polan Mary Lake Ph D |
Director |
– • – |
2020-10-23 |
4 |
OE |
$15.74 |
$588,142 |
D/D |
27,188 |
38,329 |
|
- |
|
| Polan Mary Lake Ph D |
Director |
– • – |
2020-10-12 |
4 |
S |
$275.83 |
$3,239,015 |
D/D |
(11,743) |
11,141 |
|
40% |
|
| Borkar Ratan S |
SVP, Intl Comm Operations |
• – – |
2020-09-19 |
4 |
D |
$189.31 |
$473,275 |
D/D |
(2,500) |
524 |
|
- |
|
| Borkar Ratan S |
SVP, Intl Comm Operations |
• – – |
2020-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
3,024 |
|
- |
|
| Strobeck Matthew |
Director |
– • – |
2020-09-03 |
4 |
B |
$155.60 |
$62,254 |
I/I |
400 |
38,145 |
2.1 |
29% |
|
| Strobeck Matthew |
Director |
– • – |
2020-09-02 |
4 |
B |
$166.60 |
$1,216,511 |
I/I |
7,300 |
37,745 |
2.1 |
18% |
|
| Bryant Douglas C |
President & CEO |
• • – |
2020-08-31 |
4 |
B |
$174.99 |
$874,965 |
D/D |
5,000 |
455,823 |
2.81 |
15% |
|
| Abney Michael Donald Jr. |
SVP - Distribution |
• – – |
2020-08-20 |
4 |
S |
$250.00 |
$645,500 |
D/D |
(2,582) |
6,634 |
|
23% |
|
| Abney Michael Donald Jr. |
SVP - Distribution |
• – – |
2020-08-20 |
4 |
OE |
$21.08 |
$88,143 |
D/D |
2,582 |
9,216 |
|
- |
|
| Abney Michael Donald Jr. |
SVP - Distribution |
• – – |
2020-08-19 |
4 |
S |
$250.00 |
$1,402,500 |
D/D |
(5,610) |
6,634 |
|
25% |
|
| Abney Michael Donald Jr. |
SVP - Distribution |
• – – |
2020-08-19 |
4 |
OE |
$21.08 |
$201,215 |
D/D |
5,610 |
12,244 |
|
- |
|
| Bryant Douglas C |
President & CEO |
• • – |
2020-08-11 |
4 |
B |
$234.12 |
$1,170,600 |
D/D |
5,000 |
450,823 |
2.81 |
-11% |
|
799 Records found
|
|
Page 8 of 32 |
|
|
2.54 (6.4%) 
